Article / 18 April 2018 at 7:57 GMT

Morning Report APAC: Equities roar higher as US earnings impress

APAC Sales Trading Desk / Saxo Capital Markets
Singapore
header
 
By Saxo APAC Sales Trading

chart
 Speeches
  • 20:30 – US - Fed's Dudley Has Opening Remarks at Community Bank Conference 
  • 21:15 – UK - BOE FPC's Brazier, Kohn and Taylor Testify to Lawmakers 
Overnight News

US EARNINGS BEAT ESTIMATE:
  • Goldman Sachs fixed-income trading desk and debt-underwriting division helped generate the bank's highest revenue in three years. Johnson & Johnson kicked off U.S. health care earnings with a boosted sales forecast, and UnitedHealth surged after saying its added customers. Netflix gained as much as 10% after yesterday's blowout results. 

  • The S&P 500 gained more than 1% and the Nasdaq was up more than 1.5%. Treasury yields edged lower and West Texas crude traded near $66 a barrel. 

  • We still have two weeks of earnings to be announced in the US that should continue the positive momentum and we expect the US equities to continue their rally for the time being. 

CHINA CUTS RRR

  • China cut 1% to 16% and 14% off the reserve ratio requirement for some banks, freeing up about 1.3 trillion yuan ($207 billion). Most of the funds will be used by banks to repay medium term financing, with a net 400 billion yuan being added to the system.
image
 
Foreign Exchange
chart
 
  •  Very little movement in the G10 space with only USDCHF rallying 0.6% and attempting to break the 200d MA at 0.9658. We remain in a very strong uptrend channel since mid-February. The support is at 0.9555.
  • Emerging Markets: USDEM was well offered in the NY session following the rally in equities. We should expect the selling interest to continue today. 

Vols
chart


The front end of the G10 curves are well offered with the equity rally but the back end remains well supported.
There are still a lot of buyers for the Bank of Canada meeting. 55 bps are priced in the FX market for USDCAD .

Rates
chart
 
2Y Treasury yield rose while those for the 10Y slipped, resulting in the tightest spread between the pair, as investors trimmed long-term growth expectations even as they expected the Federal Reserve to stick to two-three additional rate increases for the remainder of 2018.
10Y German government bond yield fell 1.8 Bps, resulting sovereign paper as a proxy for the Eurozone’s economy.


Commodities
commodities
 





























AOAC
 
Equities
chart
 US: 

Dow (+213 points) and S&P 500 (+28 points) stocks closed solidly higher on Tuesday, led by a rally in technology and consumer discretionary stocks. Investors welcomed a round of better-than-expected earnings reports and solid economic data releases. All three indices ended back above their 50DMA, a closely watched gauge for the short-term price momentum in a security.

Netflix Inc. NFLX, shot up 9.2% and closed at a record a day after the streaming-media company reported first-quarter results that blew past Wall Street forecasts. The stock was the biggest percentage gainer in the S&P, and it supported the overall consumer-discretionary sector.

On earnings, UnitedHealth Group UNH, rose 3.6% after it raised its outlook and reported a sharp increase in profits. The stock was one of the biggest boosts among Dow components. While, General Electric Co. GE, jumped 3.5%. The troubled industrial conglomerate is scheduled to report results later this week.

On the downside, Johnson & Johnson JNJ, slid 0.9% lower even as profit and revenue beat forecasts and the pharmaceutical and consumer products group lifted its sales outlook. Goldman Sachs GS, fell 1.7% despite reporting results that were sharply ahead of expectations.

Technology companies rallied on Tuesday. Twitter Inc. TWTR, shares surged 11% after Morgan Stanley analysts upgraded the stock to equal-weight from underweight. Shares of Alphabet Inc. GOOG, gained 3.2% while Microsoft Corp. MSFT, rose 2% and Apple Inc. AAPL, added 1.4%.


Europe:

European stocks erased an earlier loss and ended higher Tuesday after the pound pulled back from its highest level since the Brexit vote, following a mixed report on the British labour market. UK FTSE 100 ( +27 points) and DAX closed positive (+194 points), while CAC (+40 points).

Looking at individual stocks, Associated British Foods PLC (ABF), jumped 4.1% after the Primark parent said first-half pretax profit declined, but also backed its full-year guidance.

In pharmaceuticals, Genmab AS (GEN), rallied 8.7% after the Danish pharmaceutical company reported stronger-than-expected first-quarter sales of its Darzalex drug. On the other hand, Bayer AG (BAYN), added 2.8% after news its major shareholder Temasek will boost its stake in the German drug and chemicals maker.

Basic resources stocks — with their heavy exposure to China — were among the top performing sectors Tuesday, jumping 1.3% following robust GDP data from Beijing. The economy grew at 6.8% during the first three months of 2018, topping expectations. Polymetal, ArcelorMittal and Anglo American were among those leading the sectoral gains, all closing up 2% or more.

Hong Kong: 

Hang Seng Index (HSI) stocks continued the fourth day of decline. At close, Hang Seng Index headed south 252 points or 0.8% to 30,062. Investors digested the release of a raft of China data, including expectation-topping first-quarter GDP growth. The dollar also eased further while oil prices pared some overnight losses.

US Department of Commerce issued a statement on 16 April that the government has imposed a denial of export privileges on ZTE Corporation (763.HK) against acquiring sensitive technology from American enterprises for a term of seven years, due to its violation of sanctioning injunction. Shares were suspended, lasted traded was at 25.60.

Handset equipment stocks went subdued. AAC TECH (2018.HK) and SUNNY OPTICAL (02382.HK) slumped 4.6% and 5.8% and became the worst-performing blue-chippers. COWELL (01415.HK), BYD ELECTRONIC (00285.HK) and Q TECH (01478.HK) plummeted 3.6%-6.4%.

Pharmaceutical stocks mirrored the downtrend. Names like WUXI BIO (2269.HK), CSPC PHARMA (1093.HK), TRAD CHI MED (570.HK), SINO BIOPHARM (1177.HK) and FOSUN PHARMA (2196.HK) nosedived 2.5%-5.9%.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Tradingfloor.com permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Tradingfloor.com and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Tradingfloor.com is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Tradingfloor.com or as a result of the use of the Tradingfloor.com. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through Tradingfloor.com your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. Tradingfloor.com does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail